Difference between revisions of "Yasuchika Hasegawa"
(Japanese trilateralist) |
(description) |
||
| Line 1: | Line 1: | ||
{{person | {{person | ||
|constitutes=businessman,deep politician | |constitutes=businessman,deep politician | ||
| − | |description= | + | |description=Pharma executive and leader of Trilateral Commission |
|wikipedia= | |wikipedia= | ||
|image=Yasuchika Hasegakwa 20120125.jpg | |image=Yasuchika Hasegakwa 20120125.jpg | ||
| Line 7: | Line 7: | ||
|birth place=Nagato, Japan | |birth place=Nagato, Japan | ||
|nationality=Japanese | |nationality=Japanese | ||
| − | |alma_mater=Waseda University | + | |alma_mater=Waseda University |
|death_date= | |death_date= | ||
|employment={{job | |employment={{job | ||
|title=Trilateral Commission/Asia Pacific Chairman | |title=Trilateral Commission/Asia Pacific Chairman | ||
|start=2012 | |start=2012 | ||
| − | |end= | + | |end=2017 |
}}{{job | }}{{job | ||
|title=Takeda Pharmaceuticals/CEO | |title=Takeda Pharmaceuticals/CEO | ||
Revision as of 09:40, 1 April 2021
 Yasuchika Hasegawa  (businessman, deep politician) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
 | ||||||||||
| Born | 19. June, 1946 | |||||||||
| Nationality | Japanese | |||||||||
| Alma mater | Waseda University | |||||||||
| Member of | Trilateral Commission | |||||||||
Pharma executive and leader of Trilateral Commission
| ||||||||||
Yasuchika Hasegawa was been Chairman and CEO of Takeda Pharmaceutical since 2009 and the Keizai Doyukai (Japanese association of CEOs). He was chairman of the Asia-Pacific group of the Trilateral Commission.
Biography
Yasuchika was born in Nagato in June 1946. After graduating from high school in Fukuoka, he was admitted to Waseda University. He graduated in 1970 in political economy. He was hired at the end of the university by Takeda Pharmaceuticals in positions, successively, of human resources, management, and international relations.
In 1986 he became president of the German branch of Takeda Pharmaceuticals. Two years later he became President of Takeda Pharmaceutical Europe. InJune 2003[ 5 ] , he was appointed director of the company. Once president, he encourages a policy of diversification of the company's recruitment, and promotes the acquisition of foreign companies. It launches waves of recruitment of foreign executives of rival companies, benefiting from higher salaries.
Thanks to the company's positive results, his compensation rose from 223 million yen in 2009 to 301 million in 2012, before reaching 450 million in 2015. He resigned from his post at the general meeting of shareholders of Takeda Pharmaceutical Industry on June 28, 2017, becoming a consultant for the company.
Events Participated in
| Event | Start | End | Location(s) | Description |
|---|---|---|---|---|
| WEF/Annual Meeting/2011 | 26 January 2011 | 30 January 2011 | World Economic Forum Switzerland | 2229 guests in Davos, with the theme: "Shared Norms for the New Reality". |
| WEF/Annual Meeting/2012 | 25 January 2012 | 29 January 2012 | World Economic Forum Switzerland | 2113 guests in Davos |
| WEF/Annual Meeting/2013 | 23 January 2013 | 27 January 2013 | World Economic Forum Switzerland | 2500 mostly unelected leaders met to discuss "leading through adversity" |
| WEF/Annual Meeting/2014 | 22 January 2014 | 25 January 2014 | World Economic Forum Switzerland | 2604 guests in Davos considered "Reshaping The World" |
